K
Kiniksa Pharmaceuticals International, plc (KNSA)
NMS – Real Time Price. Currency in USD
45.75
-1.03 (-2.20%)
At close: Mar 27, 2026, 4:00 PM EDT
46.64
+0.89 (1.95%)
After-hours: Mar 27, 2026, 6:41 PM EDT

NMS – Real Time Price. Currency in USD
45.75
-1.03 (-2.20%)
At close: Mar 27, 2026, 4:00 PM EDT
46.64
+0.89 (1.95%)
After-hours: Mar 27, 2026, 6:41 PM EDT
This stock has a consensus price target of $51.33 based on the ratings of 9 analysts. The high is $62.00 and the low is $35.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 35 | $ 51.33 | $ 62 |
| Change | -23.50% | 12.20% | 35.52% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-02-25 | 15.85% | Wells Fargo | $50 → $53 | Maintains | Overweight |
| 2026-02-25 | 15.85% | Wedbush | $50 → $53 | Maintains | Outperform |
| 2026-02-19 | 35.52% | Canaccord Genuity | $62 | Initiates Coverage On | Buy |
| 2026-01-13 | 9.29% | Wedbush | $48 → $50 | Maintains | Outperform |
| 2025-10-29 | 20.22% | Goldman Sachs | $45 → $55 | Maintains | Buy |